Minkovitz Cynthia S, Grason Holly, Ruderman Marjory, Casella James F
Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;; Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.
Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
Am J Prev Med. 2016 Jul;51(1 Suppl 1):S39-47. doi: 10.1016/j.amepre.2016.02.019.
Despite universal newborn screening (NBS), children in the U.S. continue to experience morbidity and mortality from sickle cell disease and related causes. Recognizing that assessments of public health services and systems can improve public health system performance and ultimately health outcomes, this study examined variations in NBS program activities for sickle cell disease.
A mixed methods study included (1) a 2009 survey of NBS programs based on ten essential public health services (N=39 states with ten or more sickle cell births over a 3-year period) and (2) key informant interviews in 2011 with 13 states that had sufficient Phase 1 survey scores, black births, and variability in state legislation and geography. Key informants were from 13 NBS programs, 22 sickle cell treatment centers, and ten advocacy organizations. Analyses were conducted in 2009-2014.
Considerable variability exists across states in program activities and roles. More programs reported activities oriented to care of individuals-ensuring access to services, coordination, and provider education; fewer reported planning and analysis activities oriented to statewide policy development and system change. Numbers of activities were not related to the number of affected births. In-depth interviews identified opportunities to enhance activities that support statewide comprehensive systems of care.
NBS programs perform important public health roles that complement and enhance clinical services. Nationwide efforts are needed to enable NBS programs to strengthen population-based functions that are essential to ensuring quality of care for the entire population of children and families affected by sickle cell disease.
尽管开展了新生儿疾病筛查(NBS),但美国儿童仍因镰状细胞病及相关病因出现发病和死亡情况。认识到对公共卫生服务和系统的评估能够改善公共卫生系统绩效并最终改善健康结局,本研究调查了镰状细胞病新生儿疾病筛查项目活动的差异。
一项混合方法研究包括:(1)2009年基于十项基本公共卫生服务对新生儿疾病筛查项目进行的调查(N = 39个州,这些州在3年期间有10例或更多镰状细胞病患儿出生),以及(2)2011年对13个州进行的关键信息人访谈,这些州在第一阶段调查得分、黑人出生情况以及州立法和地理方面具有充分的变异性。关键信息人来自13个新生儿疾病筛查项目、22个镰状细胞病治疗中心和10个倡导组织。分析在2009年至2014年期间进行。
各州在项目活动和职责方面存在很大差异。更多项目报告了针对个体护理的活动——确保获得服务、协调和提供者教育;较少项目报告了针对全州政策制定和系统变革的规划和分析活动。活动数量与受影响出生人数无关。深入访谈确定了加强支持全州综合护理系统活动的机会。
新生儿疾病筛查项目发挥着重要的公共卫生作用,对临床服务起到补充和增强作用。需要在全国范围内做出努力,使新生儿疾病筛查项目能够加强基于人群的功能,这些功能对于确保为受镰状细胞病影响的所有儿童和家庭提供高质量护理至关重要。